Skip to main content

Pairings: Mar 2, 2011

Premium

Affymetrix said last week that Paul Berg will retire from its board of directors in May. Berg has been a board member of the company since its inception in 1993.


Olink Genomics has appointed a new chairman of the board and a chief business officer.

Mårten Winge
has been named chairman of the board, replacing Mats Nilsson as of October 2010. Nilsson will remain a member of the board. Previously, Winge served as CEO of Proxeon A/S, a company acquired by Thermo Fisher Scientific. Winge has 20 years of biotech tools industry experience, holding marketing and sales positions at various top life sciences firms.

Maria Hjortsmark has joined the company as its chief business officer. Previously, she was the senior brand manager at Phadia AB, which specializes in autoimmune disease diagnostics. Hjortsmark has over 20 years experience in product management, marketing and sales at companies such as Pharmacia Biotech and Pyrosequencing AB.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.